ReviewJournal of nanobiotechnology2026
Sorafenib nanomedicine in HCC: nano-bio interactions and combination therapies.
Tingxuan Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ReviewJournal of nanobiotechnology2026
Tingxuan Lu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.